Home ›
Trademark Categories ›
Pharmaceuticals ›
2014 ›
ME ›
MERSITRO
Trademark search for:
MERSITRO
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2014-10-27 — Application filed
2014-10-30 — Application filed
2014-11-06 — Application filed
2015-02-14 — Assigned to examiner
2015-02-19 — Final disposition recorded
2015-02-19 — Final disposition recorded
2015-02-19 — Final disposition recorded
2015-07-08 — Office action issued
2015-07-16 — Assigned to lie
2015-07-23 — Teas/email correspondence entered
2015-07-23 — Correspondence received in law office
2015-08-05 — Approved for pub - principal register
2015-08-11 — Law office publication review completed
2015-08-26 — Notification of notice of publication e-mailed
2015-09-15 — Published for opposition
2015-09-15 — Official gazette publication confirmation e-mailed
2015-11-10 — Noa e-mailed - sou required from applicant
2016-03-30 — Teas delete 1(b) basis received
2016-03-30 — Notice of allowance cancelled
2016-05-16 — Case assigned to intent to use paralegal
2016-06-01 — 1(b) basis deleted; proceed to registration
2016-07-05 — Registered-principal register
2021-07-05 — Courtesy reminder - sec. 8 (6-yr) e-mailed
2021-07-22 — Attorney/dom.rep.revoked and/or appointed
2021-07-22 — Teas change of domestic representatives address
2021-07-22 — Teas change of owner address received
2021-07-22 — Teas change of correspondence received
2021-07-22 — Applicant/correspondence changes (non-responsive) entered
2021-07-22 — Teas revoke/app/change addr of atty/dom rep received
2023-01-20 — Cancelled sec. 8 (6-yr)
2023-01-20 — Final status recorded
Owner Information
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE
AstraZeneca AB
Södertälje SE
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP 1800 Concord Pike, A2C Wilmington, DE 19850-5437 UNITED STATES
Filing Details
Filing Date:
2014-10-27
Status Date:
2023-01-20
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.